109 related articles for article (PubMed ID: 6377123)
1. PHI-like immunoreactivity co-locates with the VIP-containing system in human lumbosacral spinal cord.
Anand P; Gibson SJ; Yiangou Y; Christofides ND; Polak JM; Bloom SR
Neurosci Lett; 1984 May; 46(2):191-6. PubMed ID: 6377123
[TBL] [Abstract][Full Text] [Related]
2. Analysis of peptide histidine-isoleucine/vasoactive intestinal polypeptide-immunoreactive neurons in the central nervous system with special reference to their relation to corticotropin releasing factor- and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus.
Hökfelt T; Fahrenkrug J; Ju G; Ceccatelli S; Tsuruo Y; Meister B; Mutt V; Rundgren M; Brodin E; Terenius L
Neuroscience; 1987 Dec; 23(3):827-57. PubMed ID: 3125490
[TBL] [Abstract][Full Text] [Related]
3. A VIP-containing system concentrated in the lumbosacral region of human spinal cord.
Anand P; Gibson SJ; McGregor GP; Blank MA; Ghatei MA; Bacarese-Hamilton AJ; Polak JM; Bloom SR
Nature; 1983 Sep 8-14; 305(5930):143-5. PubMed ID: 6193428
[TBL] [Abstract][Full Text] [Related]
4. Survey of distribution of substance P, vasoactive intestinal polypeptide, cholecystokinin, neurotensin, Met-enkephalin, bombesin and PHI in the spinal cord of cat, dog, sloth and monkey.
Yaksh TL; Michener SR; Bailey JE; Harty GJ; Lucas DL; Nelson DK; Roddy DR; Go VL
Peptides; 1988; 9(2):357-72. PubMed ID: 2453858
[TBL] [Abstract][Full Text] [Related]
5. A VIP/PHI-containing pathway links urinary bladder and sacral spinal cord.
Gibson SJ; Polak JM; Anand P; Blank MA; Yiangou Y; Su HC; Terenghi G; Katagiri T; Morrison JF; Lumb BM
Peptides; 1986; 7 Suppl 1():205-19. PubMed ID: 3529051
[TBL] [Abstract][Full Text] [Related]
6. Molecular forms of peptide histidine isoleucine-like immunoreactivity in the gastrointestinal tract. Nonequimolar levels of peptide histidine isoleucine and vasoactive intestinal peptide in the stomach explained by the presence of a big peptide histidine isoleucine-like molecule.
Yiangou Y; Christofides ND; Blank MA; Yanaihara N; Tatemoto K; Bishop AE; Polak JM; Bloom SR
Gastroenterology; 1985 Sep; 89(3):516-24. PubMed ID: 3839480
[TBL] [Abstract][Full Text] [Related]
7. Concentrations and distribution of vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI) and peptide histidine valine (PHV) in the cerebral cortex and the suprachiasmatic nucleus of the mouse.
Mikkelsen JD; Fahrenkrug J
Brain Res; 1994 Sep; 656(1):95-107. PubMed ID: 7804850
[TBL] [Abstract][Full Text] [Related]
8. Preferential immunohistochemical localization of vasoactive intestinal polypeptide (VIP) in the sacral spinal cord of the cat: light and electron microscopic observations.
Honda CN; Réthelyi M; Petrusz P
J Neurosci; 1983 Nov; 3(11):2183-96. PubMed ID: 6195317
[TBL] [Abstract][Full Text] [Related]
9. Localization of vasoactive intestinal peptide immunoreactivity in human foetus and newborn infant spinal cord.
Charnay Y; Chayvialle JA; Said SI; Dubois PM
Neuroscience; 1985 Jan; 14(1):195-205. PubMed ID: 3883230
[TBL] [Abstract][Full Text] [Related]
10. The distributions of PHI and VIP in porcine gut and their co-localisation to a proportion of intrinsic ganglion cells.
Bishop AE; Polak JM; Yiangou Y; Christofides ND; Bloom SR
Peptides; 1984; 5(2):255-9. PubMed ID: 6382195
[TBL] [Abstract][Full Text] [Related]
11. Effect of peripheral nerve section and nerve crush on spinal cord neuropeptides in the rat; increased VIP and PHI in the dorsal horn.
McGregor GP; Gibson SJ; Sabate IM; Blank MA; Christofides ND; Wall PD; Polak JM; Bloom SR
Neuroscience; 1984 Sep; 13(1):207-16. PubMed ID: 6208507
[TBL] [Abstract][Full Text] [Related]
12. Distribution and localization of neuromedin B-like immunoreactivity in pig, cat and rat spinal cord.
Namba M; Ghatei MA; Gibson SJ; Polak JM; Bloom SR
Neuroscience; 1985 Aug; 15(4):1217-26. PubMed ID: 2413389
[TBL] [Abstract][Full Text] [Related]
13. The distribution and chromatographic characterization of PHI (peptide histidine isoleucine amide)-27-like peptides in rat and porcine brain.
Beinfeld MC; Korchak DM; Roth BL; O'Donohue TL
J Neurosci; 1984 Nov; 4(11):2681-8. PubMed ID: 6548767
[TBL] [Abstract][Full Text] [Related]
14. The distribution and origin of VIP in the spinal cord of six mammalian species.
Gibson SJ; Polak JM; Anand P; Blank MA; Morrison JF; Kelly JS; Bloom SR
Peptides; 1984; 5(2):201-7. PubMed ID: 6433328
[TBL] [Abstract][Full Text] [Related]
15. VIP terminals, axons, and neurons: distribution throughout the length of monkey and cat spinal cord.
LaMotte CC; de Lanerolle NC
J Comp Neurol; 1986 Jul; 249(1):133-45. PubMed ID: 3525616
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal polypeptide and substance P in primary afferent pathways to the sacral spinal cord of the cat.
Kawatani M; Erdman SL; de Groat WC
J Comp Neurol; 1985 Nov; 241(3):327-47. PubMed ID: 2418069
[TBL] [Abstract][Full Text] [Related]
17. Segmental analysis of neuropeptide concentrations in normal human spinal cord.
Benarroch EE; Aimone LD; Yaksh TL
Neurology; 1990 Jan; 40(1):137-44. PubMed ID: 2296359
[TBL] [Abstract][Full Text] [Related]
18. Peptide histidine isoleucine- and vasoactive intestinal polypeptide-like immunoreactivity coexist in rat hypophysial portal blood.
Shimatsu A; Kato Y; Inoue T; Christofides ND; Bloom SR; Imura H
Neurosci Lett; 1983 Dec; 43(2-3):259-62. PubMed ID: 6689501
[TBL] [Abstract][Full Text] [Related]
19. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome.
Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426
[TBL] [Abstract][Full Text] [Related]
20. Studies on the location and release of cholecystokinin and vasoactive intestinal peptide in rat and cat spinal cord.
Yaksh TL; Abay EO; Go VL
Brain Res; 1982 Jun; 242(2):279-90. PubMed ID: 6896838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
